1. Home
  2. PBYI vs PPIH Comparison

PBYI vs PPIH Comparison

Compare PBYI & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • PPIH
  • Stock Information
  • Founded
  • PBYI 2010
  • PPIH 1993
  • Country
  • PBYI United States
  • PPIH United States
  • Employees
  • PBYI N/A
  • PPIH 640
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • PPIH Pollution Control Equipment
  • Sector
  • PBYI Health Care
  • PPIH Industrials
  • Exchange
  • PBYI Nasdaq
  • PPIH Nasdaq
  • Market Cap
  • PBYI 153.2M
  • PPIH 128.3M
  • IPO Year
  • PBYI N/A
  • PPIH N/A
  • Fundamental
  • Price
  • PBYI $2.92
  • PPIH $16.08
  • Analyst Decision
  • PBYI Strong Buy
  • PPIH
  • Analyst Count
  • PBYI 1
  • PPIH 0
  • Target Price
  • PBYI $7.00
  • PPIH N/A
  • AVG Volume (30 Days)
  • PBYI 416.5K
  • PPIH 53.5K
  • Earning Date
  • PBYI 11-07-2024
  • PPIH 12-27-2024
  • Dividend Yield
  • PBYI N/A
  • PPIH N/A
  • EPS Growth
  • PBYI 492.79
  • PPIH 214.84
  • EPS
  • PBYI 0.47
  • PPIH 1.90
  • Revenue
  • PBYI $243,569,000.00
  • PPIH $157,704,000.00
  • Revenue This Year
  • PBYI N/A
  • PPIH N/A
  • Revenue Next Year
  • PBYI N/A
  • PPIH N/A
  • P/E Ratio
  • PBYI $6.26
  • PPIH $8.28
  • Revenue Growth
  • PBYI 6.30
  • PPIH 13.34
  • 52 Week Low
  • PBYI $2.23
  • PPIH $6.83
  • 52 Week High
  • PBYI $7.73
  • PPIH $17.58
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 47.45
  • PPIH 55.04
  • Support Level
  • PBYI $2.82
  • PPIH $16.57
  • Resistance Level
  • PBYI $3.12
  • PPIH $17.13
  • Average True Range (ATR)
  • PBYI 0.20
  • PPIH 0.81
  • MACD
  • PBYI -0.03
  • PPIH -0.13
  • Stochastic Oscillator
  • PBYI 14.71
  • PPIH 50.17

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About PPIH Perma-Pipe International Holdings Inc.

Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, Middle East, Europe, India and other countries.

Share on Social Networks: